{"id":"W2980451885","doi":"10.1182/blood.v122.21.2723.2723","title":"Bosutinib As Therapy For Chronic Phase Chronic Myeloid Leukemia Following Resistance Or Intolerance To Imatinib: 48-Month Update","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bosutinib; Medicine; Nilotinib; Internal medicine; Imatinib; Dasatinib; Gastroenterology; Imatinib mesylate; Myeloid leukemia; Tyrosine-kinase inhibitor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002490694,0.0005166957,0.000911517,0.0007525517,0.00020663,0.001170126,0.0007264266,0.001503345,0.00168862],"category_scores_gemma":[0.002168192,0.0001911648,0.0006644856,0.001051645,0.000410151,0.001194625,0.000364713,0.002154896,0.0008395699],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007306809,"about_ca_system_score_gemma":0.0009743961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007715979,"about_ca_topic_score_gemma":0.003021495,"domain_scores_codex":[0.9995387,0.0001030984,0.0001102331,0.00005653099,0.0001409796,0.00005053915],"domain_scores_gemma":[0.9980596,0.0006539811,0.0004162642,0.00004063179,0.0005520979,0.0002773802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0008594978,0.0002543677,0.0028482,0.002912781,0.0001988246,0.0006415712,0.00008231509,0.0005511829,0.00152822,0.0008755839,0.07738677,0.9118606],"study_design_scores_gemma":[0.0007054246,0.002936515,0.02093851,0.004090157,0.0008168317,0.004162168,0.0001532777,0.001253244,0.001254769,0.0006605833,0.962975,0.0000536197],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.0138692,0.9607425,0.001110064,0.01285767,0.003605737,0.0000575147,0.0003972577,0.0001071237,0.007252873],"genre_scores_gemma":[0.04075093,0.9329152,0.001674739,0.009681751,0.01073355,0.00008144599,0.0009135595,0.00003299674,0.003215903],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.002490694,"threshold_uncertainty_score":0.01317221,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01628572101885572,"score_gpt":0.307046145568339,"score_spread":0.2907604245494833,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}